Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

274 search results for ‘*’

Manufacture Supply Chain

Supply Chains: Real-world Problems, Digital Solutions

| Maryam Mahdi

Overcoming supply chain woes will require digital intervention.


Business & Regulation Business Practice

Done Deal: Creating Anti-COVID-19 Equity

| Maryam Mahdi

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.


Manufacture Bioprocessing - Upstream & Downstream

uBioprocess

| Angus Stewart

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

Business & Regulation Advanced Medicine

mRNA + Cell and Gene = ???

| Angus Stewart

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Business & Regulation Trends & Forecasts

The Magnificent Seven

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

Manufacture Small Molecules

The Manipulation of Genetic Machinery

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Business & Regulation COVID-19

The Biggest Moments of 2021

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

Discovery & Development Standards & Regulation

Who’s the Coolest?

| Angus Stewart

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.

Business & Regulation COVID-19

A View on the Future of R&D From the UK

| Maryam Mahdi

Pharma experts convened at the Pharmaceutical Industry Network Group’s annual conference to discuss the UK’s position in pharmaceutical innovation.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register